Sinopharm Group: Net profit in 2025 is expected to increase by 76.80% year-on-year

Every AI Express, April 1, Guo Yao Yi Zhi (000028.SZ) announced that the company released its 2025 annual report. The company achieved operating revenue of 73.42B yuan, down 1.29% year over year; net profit attributable to shareholders of the listed company was 1.14B yuan, up 76.80%. The company plans to distribute to all shareholders a cash dividend of 6.16 yuan per 10 shares (tax included), issue 1 bonus share for every 10 shares (tax included), and will not convert capital reserve into share capital.

Daily Economic News

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin